tirzepatide class action lawsuit Ozempic Lawsuit: Thousands Are Now Suing for What the Drug Did to Their Bodies Zepbound Lawsuit [2026] | Gastrointestinal

Each year, an estimated 300,000 adults in the United States die of causes related to obesity [2] According to the guidelines of the National Institute of Health (NIH) regarding the treatment of obesity, weight loss drugs approved by the FDA [US Food and Drug Administration] may only be used as part of a comprehensive weight loss program, including dietary therapy and physical activity, for patients with a BMI [body mass index] of 30 with no concomitant obesity-related risk factors or diseases, and for patients with a BMI of 27 with concomitant obesity-related risk factors or diseases[3].The risk factors and diseases considered important enough to warrant pharmacotherapy at a BMI of 27--29.9 are hypertension, dyslipidemia, coronary heart disease (CHD), type 2 diabetes, and sleep apnea [3]

Your personal plan is confirmed at a consultation

* Home delivery: Approved prescriptions are fulfilled through licensed U.S

Their website featured before/after imagery and language that could be interpreted as therapeutic claims

The most common form in research settings is subcutaneous injection, typically administered 30-60 minutes before sleep